We recently published a list of 10 Best Dividend Kings Stocks to Invest in Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend king ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with AbbVie Inc. (NYSE: ABBV) to include the discovery of T ...

NORTH CHICAGO, Ill. and ROCKVILLE, Md., Jan. 13, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program. ABBV-RGX-314 ...

AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with AbbVie Inc. (NYSE: ABBV) to include the discovery of T-cell engagers (TCE) in oncology. The expansion ...

Movers & Shakers: Ardagh, Disney, Alvarez & Marsal, Lauder Teacher, AbbVie, 150Bond, Dublin Gazette Business Post head of news Peter O’Dwyer reveals who’s on the move in the entertainment, legal, ...

Italian authorities released the director of a notorious detention camp who had been arrested in Turin on an ICC war crimes warrant. Italian police were acting on an arrest warrant from the ...

President Donald Trump talks to the media at a public press event following the RNC debate in Houston, Texas in February 2016. Picture: Stock_photo_world/Shutterstock ...

(courtesy photo) Thousand Oaks-based Capsida Biotherapeutics will be receiving $40 million from biotech giant AbbVie after the South San Francisco-based company exercised an option for the first ...

AbbVie Inc. will record a $3.5 billion charge after a schizophrenia drug it gained in the purchase of Cerevel Therapeutics Inc. failed in clinical trials. The experimental drug, emraclidine, failed to ...